Sox-7 CRISPR/Cas9 KO Plasmid (h): sc-402935
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Sox-7 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Sox-7 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sox-7 CRISPR/Cas9 KO Plasmid (h) | sc-402935 | 20 µg | $397.00 |
Overview
SOX7 encodes the human transcription factor Sox-7, a member of the SOX family that binds DNA via an HMG box to regulate gene expression programs controlling cell fate decisions. Sox-7 is implicated in vascular and endodermal development and influences endothelial differentiation, migration, and barrier-related transcriptional networks, including crosstalk with Wnt/β-catenin and Notch-associated signaling. Altered SOX7 expression has been reported across multiple tumor contexts and is associated with changes in proliferation, invasion, and epithelial–mesenchymal transition-related pathways. Because Sox-7 integrates developmental and lineage-specifying signals, it is frequently studied in models of angiogenesis, stem cell differentiation, and cancer biology.
Sox-7 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SOX7 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SOX7 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SOX7 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sox-7 protein expression.
This CRISPR knockout system enables efficient generation of SOX7-deficient cell models for investigation of Sox-7 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting SOX7 exon(s) critical for Sox-7 function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple SOX7 genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by Sox-7 CRISPR/Cas9 KO Plasmid (h) and Sox-7 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the SOX7 locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by Sox-7 HDR Plasmid (h) and Sox-7 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by SOX7 homology arms to support homology-directed repair at defined SOX7 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.